Related Experiment Video
Updated: Feb 16, 2026

Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
Published on: March 20, 2016
Aspirin suppresses TNF-α-induced MMP-9 expression via NF-κB and MAPK signaling pathways in RAW264.7 cells
Ping Zhang1,2, Chao Wu3, Xiao-Hui Huang1
1Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Abstract:
Numerous studies have indicated that the expression of matrix metalloproteinase-9 (MMP-9) contributes to the atherosclerotic plaque hemorrhage and rupture. Aspirin, a non-steroidal anti-inflammation drug, has been known for its anti-platelet effect in the prevention of the vascular complications of atherosclerosis. The present study aimed to investigate the pharmacological effects of aspirin on tumor necrosis factor-α (TNF-α)-induced MMP-9 expression and the underlying molecular mechanisms in murine macrophage RAW264.7 cells. Western blot analysis indicated that the protein level of MMP-9 was reduced by aspirin in a dose-dependent manner. In addition, downregulation of MMP-9 mRNA and activity were detected in aspirin-treated cells using quantitative polymerase chain reaction and a gelatin zymography assay separately. It was also observed that aspirin has a suppressive effect on the activation of nuclear factor (NF)-κB and inhibits the phosphorylation of mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinases 1/2, p38 and c-Jun N-terminal kinase. Furthermore, subsequent to inhibition of the MAPK pathway by specific inhibitors (PD98059, SB203580 and SP600125), the expression of MMP-9 was reduced, indicating that the inhibitory effect of aspirin on MMP-9 in TNF-α-treated RAW264.7 cells may be, at least in part, through suppression of NF-κB activation and the MAPK pathway. These findings support the notion that aspirin has therapeutic potential application in the prevention and treatment of atherosclerosis disease.
Insights
Aspirin reduces matrix metalloproteinase-9 (MMP-9) expression in macrophages by inhibiting NF-κB and MAPK pathways. This suggests aspirin
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Matrix metalloproteinase-9 (MMP-9) expression is linked to atherosclerotic plaque rupture.
- Aspirin is known for its anti-platelet effects in preventing atherosclerosis complications.
Purpose of the Study:
- To investigate aspirin's effects on tumor necrosis factor-α (TNF-α)-induced MMP-9 expression in murine macrophages.
- To elucidate the molecular mechanisms underlying aspirin's action on MMP-9.
Main Methods:
- Western blot analysis to assess MMP-9 protein levels.
- Quantitative polymerase chain reaction (qPCR) for MMP-9 mRNA expression.
- Gelatin zymography assay to measure MMP-9 activity.
- Inhibition of NF-κB and MAPK pathways to determine aspirin's mechanism.
Main Results:
- Aspirin dose-dependently reduced MMP-9 protein, mRNA, and activity.
- Aspirin suppressed NF-κB activation and MAPK phosphorylation (ERK1/2, p38, JNK).
- Inhibiting MAPK pathways reduced MMP-9 expression, confirming aspirin's mechanism.
Conclusions:
- Aspirin inhibits TNF-α-induced MMP-9 expression in macrophages.
- Aspirin's mechanism involves suppressing NF-κB activation and the MAPK pathway.
- Aspirin demonstrates therapeutic potential for preventing and treating atherosclerosis.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
MAPK Signaling Cascades
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
What is Cell Signaling?

